# Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412C

> **NCT01312454** · PHASE2 · TERMINATED · sponsor: **Alcon Research** · enrollment: 4 (actual)

## Conditions studied

- Open-angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** AL-59412C injectable solution
- **DRUG:** Travoprost injectable solution
- **DRUG:** AL-59412C Vehicle

## Key facts

- **NCT ID:** NCT01312454
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-06
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Management decision
- **Last updated:** 2013-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01312454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01312454, "Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412C". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01312454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*